China Pharma Holdings, Inc. Common Stock
Key Metrics
Market Snapshot
About
China Pharma Holdings, Inc. (CPHI) is a specialty pharmaceutical company based in Haikou, China, primarily known for developing, manufacturing, and marketing a range of generic drugs and treatments for the Chinese market.
The company's product portfolio includes various dosage forms such as dry powder injectables, liquid injectables, tablets, capsules, and oral solutions. Its offerings target several therapeutic areas, including treatments for cardiovascular and cerebrovascular conditions like hypertension and cerebral thrombosis, anti-infectives for respiratory and urinary tract infections, and medications for digestive system diseases. Examples of its branded products include Cerebroprotein Hydroloysate for memory issues, Gastrodin for neurological symptoms, and Candesartan for hypertension. It also produces a food supplement called Noni Enzyme, sanitizers, and masks.
China Pharma Holdings sells its products primarily to hospitals and over-the-counter pharmacies across China. The company distributes its pharmaceuticals through a network of provincial and municipal pharmaceutical logistics companies, which act as intermediaries to get its medicines to end consumers. Its operational focus remains within the People's Republic of China.